ResearcherNagoya University HospitalNo recent work listed

Hiroki Nakajima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0518-8156; OpenAlex author ID A5023958655. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer. Co-author DOI 10.1007/s10147-023-02321-1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shunsuke Onoe · 1 shared paper, 2023 · strength 0.17
- Paper Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borde… DOI 10.1007/s10147-023-02321-1 ↗
Junpei Yamaguchi · 1 shared paper, 2023 · strength 0.17
- Paper Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borde… DOI 10.1007/s10147-023-02321-1 ↗
Yukihiro Yokoyama · 1 shared paper, 2023 · strength 0.17
- Paper Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borde… DOI 10.1007/s10147-023-02321-1 ↗
Yasuhiro Kodera · 1 shared paper, 2023 · strength 0.17
- Paper Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borde… DOI 10.1007/s10147-023-02321-1 ↗
Tomoki Ebata · 1 shared paper, 2023 · strength 0.17
- Paper Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borde… DOI 10.1007/s10147-023-02321-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.